SMi Reports: Interactive workshop overview for SMi's 22nd Annual
For this year’s conference, industry leaders and key profiles from leading pharmaceutical organisations will be brought together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials.
The issue of developing and commercialising novel antibiotics whilst simultaneously making a return for investors continues to be a big problem. This year’s Superbugs & Superdrugs event aims to address these issues via a series of informative presentations by an international gathering of senior industry experts, scientific pioneers, and academics.
For interested individuals, the final early bird saving of
The upcoming Superbugs & Superdrugs 2020 will host 2 post-conference workshops taking place on
Workshop A: "Development of Non-Traditional Agents and Alternatives to Antibiotics" led by
Workshop B: "Anti-microbial Resistance and Pathogenic Fungi" led by
These interactive workshops will discuss a variety of topics such as: the in vitro and in vivo developments of non-traditional antibacterial agents, the emergence of multi-drug resistance strains pose substantial health threats and many more.
The full agenda and speaker line-up and workshop information is available online at www.superbugssuperdrugs.com/PR3
For sponsorship enquiries contact
For media enquiries, contact
Superbugs & Superdrugs 2020
Conference: 30–31 March 2020
Workshops:
www.superbugssuperdrugs.com/PR3
#SMiBugs
Contact Information:
+44 (0) 20 7827 6000
Contact via Email
http://www.superbugssuperdrugs.com/PR3
Read the full story here: https://www.pr.com/press-release/803171
Press Release Distributed by PR.com
Copyright © 2020 PR.com and its licensors
, source